Nationales Referenzzentrum für Clostridium diffici...

2018:

• Tschudin-Sutter S, Kuijper EJ, Durovic A, Vehreschild MJGT, Barbut F, Eckert C, Fitzpatrick F, Hell M, Norèn T, O'Driscoll J, Coia J, Gastmeier P, von Müller L, Wilcox MH, Widmer AF; Committee. Guidance document for prevention of Clostridium difficile infection in acute healthcare settings.

• Seugendo M, Janssen I, Lang V, Hasibuan I, Bohne W, Cooper P, Daniel R, Gunka K, Kusumawati RL, Mshana SE, von Müller L, Okamo B, Ortlepp JR, Overmann J, Riedel T, Rupnik M, Zimmermann O, Groß U. Prevalence and Strain Characterization of Clostridioides (Clostridium) difficile in Representative Regions of Germany, Ghana, Tanzania and Indonesia - A Comparative Multi-Center Cross-Sectional Study

• Bletz, S, Janezic, S, Harmsen, D, Rupnik, M, Mellmann, A: Defining and Evaluating a Core Genome Multilocus Sequence Typing Scheme for Genome-Wide Typing of Clostridium difficile. J Clin Microbiol. 2018 Apr 4.

• Berger FK, Rasheed SS, Araj GF, Mahfouz R, Rimmani HH, Karaoui WR, Sharara AI, Dbaibo G, Becker SL, von Müller L, Bischoff M, Matar G, Gärtner B: Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon. Int J Med Microbiol 2018.

• Berger F, Mellmann A, von Müller L, Gärtner B: Ausbruchsuntersuchungen bei Clostridium (Clostridioides) difficle. Epid Bull  2018;14:137 - 139.

2017:

• Simon A, Schmid S, von Müller L: Antibiotic Stewardship in Paediatric Inpatients and C. difficile Associated Disease?. Klin Padiatr. 2017 Mar;229(2):102.

• Simon A, Mock M, Graf N, von Müller L: Investigation of Clostridium difficile ribotypes in symptomatic patients of a German pediatric oncology center. Eur J Pediatr. 2017 Dec 22.

• Sharara A, Karaoui WR, Shayto R, Rimmani HH, Chalhoub J, Zahreddine N, El Sabbagh R, Kanj S, Mahfouz R, Araj G, Rasheed S, Berger F, Gärtner B, Matar G. Hypervirulent Clostridium difficile Strains Are Rarely Associated With Nosocomial CDI in Adults in Lebanon: Results From a Prospective Study on the Incidence, Risk Factors for Relapse, and Outcome of Nosocomial CSI. The American Journal of Gastroenterology 112, S45-S104 (2017).

• Davies K, Davis G, Barbut F, Eckert C, Petrosillo N, Pisapia R, Reigadas E, Emilio Bouza, Berger F, Herrmann M, Wilcox MH: Multivariate analysis of factors affecting Clostridium difficile infection rates; the more you look, the more you find, but should you believe what you see?. ECCMID, Vienna, Austria 2017.
• Berger F, Bischoff M, Strauß C, von Müller L, Gärtner B.: Auftreten von Clostridium difficile Ribotyp 176 in Deutschland.Epid Bull 2017;10:93- 95.
• Färber J, Illiger S, Berger F, Gärtner B, von Müller L, Lohmann C.H, Bauer K, Grabau C, Zibolka S, Schlüter D, Geginat G: Management of a Cluster of Clostridium difficile infections among patients with osteoarticular infections. BioMed Central, Antimicrobial Resistance & Infection Control 2017.
• Berger F: Clostridium difficile: Routine diagnostics in the medical laboratory. LabBook-Advertorial. 06/13/2017

2016:

• Berger F, Becker SL, von Müller L, Gärtner, B.: FAQ (Frequently Asked Questions/Häufig gestellte Fragen) für behandelnde Ärzte von Patienten mit Clostridium difficile-Infektionen. Der MIKROBIOLOGE, Heft 4/2016.
• von Müller L.:Aktuelles zu Clostridium-difficile-Infektionen (New aspects on Clostridium difficile infection).Dtsch med Wochenschr 2016; 141(16): 1144-1147.
• Berger F, Gfrörer S, Becker SL, Baldan R, Cirillo M, Nimmesgern A, Herrmann M, Gärtner B, von Müller L.: Changing epidemiology of Clostridium difficile in Europe – experiences from an unexpected ribotype 018 outbreak in southern Germany, DGHM Ulm 2016.
• Davies KA, Davis GL, Barbut F, Eckert C, Petrosillo N, Pisapia R, Reigadas-Ramirez E, Bouza E, Berger F, Herrmann M, Wilcox MH.: Seasonality of C. difficile Infection (CDI) Case Rates:  Myth or Reality?.  ASM Microbe 2016 Boston.
• Davies KA, Davis GL, Barbut F, Eckert C, Spigaglia P, Barbanti F, Herrmann M, Berger F, Bouza E, Reigadas-Ramirez E, Wilcox MH.: Adverse outcomes for missed cases of CDI; results from retrospective data collection on patients with samples received during the EUropean, multi-centre, prospective bi-annual point prevalence study of CLostridium difficile Infection in hospitalised patients with Diarrhoea (EUCLID2). ECCMID 2016, Amsterdam.
• Davies KA, Lawrence J, Berry C, Davis GL, Yu H, Cai B, Gonzalez E, Prantner I, Kurcz A, Macovei I, Pituch H, Nováková E, Nyč O, Herrmann M, Berger F, Cornely O, Vehreschild M, Pedneault L, Wilcox MH.: Observational Study of Risk factors for Clostridium difficile Infection in Hospitalised Patients with Infective Diarrhoea (ORCHID): Consistency of Risk Factors. ID Week 2016 Louisiana.

2015:

• Weichert S, Simon A, von Müller L, Adam R, Schroten H.: Clostridium-difficile-assoziierte Infektionen im Kindes- und Jugendalter. Monatsschrift Kinderheilkunde (2015) 163: 427.
• S2k-Leitlinie Gastrointestinale Infektionen und Morbus Whipple.
• Tracing the Spread of Clostridium difficile Ribotype 027 in Germany Based on Bacterial Genome Sequences.
• Molecular and culture-based diagnosis of Clostridium difficile isolates from Côte d'Ivoire after prolonged storage at disrupted cold chain conditions.
• Combined stool-based multiplex PCR and microscopy for enhanced pathogen detection in patients with persistent diarrhoea and asymptomatic controls from Côte d'Ivoire.
• Epidemiology of Clostridium difficile in Germany based on a single center long-term surveillance and German-wide genotyping of recent isolates provided to the advisory laboratory for diagnostic reasons.
• Clostridium difficile infections among adults and children in Mwanza/Tanzania is it an underappreciated pathogen among immunocompromised patients in sub-Saharan Africa?

2014:

• Schwer verlaufende Clostridium-difficile-Infektionen: IfSG-Surveillancedaten von 2013.
• Detection of nosocomial Clostridium difficile infections with toxigenic strains despite negative toxin A and B testing on stool samples.
• Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID).

2013:

• Persistent digestive disorders in the tropics: causative infectious pathogens and reference diagnostic tests.

2012:

• Aktuelle Daten und Trends zur Antibiotikaresistenzentwicklung von Clostridium difficile.